Proteome Inc
Advertisement
Inotek Pharmaceuticals is a privately held biotechnology company located in Lexington, Massachusetts, dedicated to the discovery and development of innovative drugs aimed at treating serious diseases of the eye, including glaucoma, ocular hypertension, and age-related macular degeneration. The company's lead program, trabodenoson (INO-8875), is a novel adenosine mimetic that targets the A1 sub-receptor to effectively lower intraocular pressure associated with open-angle glaucoma.
With a robust pipeline of drug candidates and a management team experienced in advancing clinical programs towards commercialization, Inotek is committed to improving patient outcomes through novel therapeutic approaches. The company has successfully completed multiple Phase 1 and Phase 2 clinical trials for trabodenoson, demonstrating its potential as an effective treatment option in managing ocular diseases.
Generated from the website
Also at this address
You might also like
Advertisement